JP2016515564A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515564A5
JP2016515564A5 JP2016504702A JP2016504702A JP2016515564A5 JP 2016515564 A5 JP2016515564 A5 JP 2016515564A5 JP 2016504702 A JP2016504702 A JP 2016504702A JP 2016504702 A JP2016504702 A JP 2016504702A JP 2016515564 A5 JP2016515564 A5 JP 2016515564A5
Authority
JP
Japan
Prior art keywords
formula
compound
acid
composition
facbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016504702A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016515564A (ja
JP6500011B2 (ja
Filing date
Publication date
Priority claimed from GBGB1305687.4A external-priority patent/GB201305687D0/en
Application filed filed Critical
Publication of JP2016515564A publication Critical patent/JP2016515564A/ja
Publication of JP2016515564A5 publication Critical patent/JP2016515564A5/ja
Application granted granted Critical
Publication of JP6500011B2 publication Critical patent/JP6500011B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016504702A 2013-03-28 2014-03-28 放射標識法 Active JP6500011B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1305687.4A GB201305687D0 (en) 2013-03-28 2013-03-28 Radiolabelling process
GB1305687.4 2013-03-28
PCT/EP2014/056344 WO2014154886A1 (en) 2013-03-28 2014-03-28 Radiolabelling process

Publications (3)

Publication Number Publication Date
JP2016515564A JP2016515564A (ja) 2016-05-30
JP2016515564A5 true JP2016515564A5 (enExample) 2017-04-27
JP6500011B2 JP6500011B2 (ja) 2019-04-10

Family

ID=48444922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016504702A Active JP6500011B2 (ja) 2013-03-28 2014-03-28 放射標識法

Country Status (12)

Country Link
US (2) US9999692B2 (enExample)
EP (1) EP2978456B1 (enExample)
JP (1) JP6500011B2 (enExample)
KR (1) KR102218249B1 (enExample)
CN (1) CN105120905B (enExample)
AU (1) AU2014242897B2 (enExample)
CA (1) CA2908029C (enExample)
ES (1) ES2864702T3 (enExample)
GB (1) GB201305687D0 (enExample)
MX (1) MX368061B (enExample)
RU (1) RU2675371C2 (enExample)
WO (1) WO2014154886A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
US20220001034A1 (en) * 2014-06-30 2022-01-06 Ge Healthcare Limited Novel formulation and method of synthesis
GB201621864D0 (en) * 2016-12-21 2017-02-01 Ge Healthcare Ltd Solid phase conditioning

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
CN101180272B (zh) 2005-05-23 2012-04-25 日本医事物理股份有限公司 有机化合物及利用该化合物的放射性卤素标记有机化合物的制造方法
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
WO2007001940A2 (en) 2005-06-23 2007-01-04 Emory University Imaging agents
DK2017258T3 (da) * 2006-05-11 2012-07-09 Nihon Mediphysics Co Ltd Fremgangsmåde til fremstilling af en radioaktiv fluormærket organisk forbindelse
KR101497406B1 (ko) * 2006-12-21 2015-03-02 니혼 메디피직스 가부시키가이샤 방사성 화상 진단제
CN101636183B (zh) * 2007-02-13 2014-03-19 日本医事物理股份有限公司 放射性诊断显像剂的制备方法
DK2230229T3 (en) 2007-12-19 2017-01-23 Nihon Mediphysics Co Ltd Process for the preparation of radioactive-fluoro-labeled organic compound
NZ600791A (en) * 2009-10-08 2014-02-28 Ge Healthcare Ltd Solid phase extraction purification technique
KR20130132892A (ko) * 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
RU2623163C2 (ru) * 2011-12-21 2017-06-22 ДжиИ ХЕЛТКЕР ЛИМИТЕД Композиция 18f- флуцикловина в цитратных буферах
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process

Similar Documents

Publication Publication Date Title
EA201290907A1 (ru) Улучшенные микрокапсулы и их получение
JP2012515142A5 (enExample)
JP2017520550A5 (enExample)
JP2013535220A5 (enExample)
JP2016520672A5 (enExample)
JP2012526842A5 (enExample)
JP2015524409A5 (enExample)
JP2012020997A5 (enExample)
JP2013010749A5 (ja) カルバゾール化合物
JP2015518821A5 (enExample)
CY1119452T1 (el) Μια μεθοδος παρασκευης 2-αιθοξυ-1-(2'-((υδροξυamino) ιμινομεθυλο) διφαινυλ-4-υλο) μεθυλο)-1η- βενζο (d) ιμιδαζολο-7-καρβοξυλικο οξυ και τους εστερες αυτου
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
CO6231027A2 (es) Metodos e intermediarios para preparar compuestos de lactama lactoma de 8 atomos de carbono activos como inhibidores de renina
RU2016147507A (ru) Новая композиция и способ синтеза
JP2016515564A5 (enExample)
EP2687505A4 (en) METHOD FOR PRODUCING A DINITRIL COMPOUND
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
JP2014510043A5 (enExample)
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
AR086451A1 (es) Derivados de 2-amino-3-(imidazol-2-il)piridin-4-ona, preparacion de los mismos y una composicion farmaceutica en base al compuesto
RU2015138540A (ru) Способ радиоактивного мечения
WO2015143019A3 (en) Gaseous f-18 technologies
JP2013522207A5 (enExample)
JP2013527149A5 (enExample)
JP2013507343A5 (enExample)